Filing Details

Accession Number:
0000874716-23-000145
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-08 17:00:21
Reporting Period:
2023-12-07
Accepted Time:
2023-12-08 17:00:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1389046 F James Polewaczyk One Idexx Drive
Westbrook ME 04092
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-07 4,956 $206.94 15,006 No 4 M Direct
Common Stock Acquisiton 2023-12-07 6,680 $288.78 21,686 No 4 M Direct
Common Stock Disposition 2023-12-07 3,116 $520.19 18,570 No 4 S Direct
Common Stock Disposition 2023-12-07 3,378 $521.00 15,192 No 4 S Direct
Common Stock Disposition 2023-12-07 1,202 $522.31 13,990 No 4 S Direct
Common Stock Disposition 2023-12-07 3,940 $523.56 10,050 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right-to-buy) Disposition 2023-12-07 4,956 $0.00 4,956 $206.94
Common Stock Non-Qualified Stock Option (right-to-buy) Disposition 2023-12-07 6,680 $0.00 6,680 $288.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
755 2029-02-13 No 4 M Direct
2,226 2030-02-13 No 4 M Direct
Footnotes
  1. Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on September 29, 2023.
  2. Represents the weighted average price of the shares sold ranging from a low of $519.73 to a high of $520.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  3. Represents the weighted average price of the shares sold ranging from a low of $520.74 to a high of $521.235 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  4. Represents the weighted average price of the shares sold ranging from a low of $521.99 to a high of $522.935 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  5. Represents the weighted average price of the shares sold ranging from a low of $523.05 to a high of $523.885 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  6. Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020.
  7. Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.